AS

Anil Surendranath Gupta

Active Director Director DIN 00197355
DIN 00197355 First appointment Oct 1983 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Oct 1983
Shareholding value •••• Premium profile

About Anil Surendranath Gupta

Data last updated:

Anil Surendranath Gupta is a Director at Zen Pharma Private Limited (since 1998), Managing Director at Adit Containers Private Limited (since 1983) and Director at Adit Pharma Private Limited (since 1991), and holds 4 more current directorships. The companies operate in Pharma, Packaging and Financial Services. The 7 current companies with reported revenue have a combined latest revenue of ₹146 Cr; the largest is Zen Pharma Private Limited at ₹119 Cr (FY 2024).

DIN 00197355
Primary Designation Director
Industry Pharma
First Appointment 25 Oct 1983
Oldest Company Age 43 yrs
Largest company Zen Pharma Private Limited · ₹119 Cr (FY 2024)
Combined revenue ₹146 Cr across 7 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zen Pharma Private Limited U24239MH1995PTC089178
Director29 May 19981995₹119 Cr (FY 2024)Active
Adit Containers Private Limited U28100MH1983PTC031185
Managing Director25 Oct 19831983₹12.21 Cr (FY 2025)Active
Adit Pharma Private Limited U24239MH1991PTC060785
Director15 Mar 19911991₹7.64 Cr (FY 2025)Active
Adit Leasing And Finance Pvt Ltd U65920MH1987PTC043611
Director01 Jun 19871987₹2.90 Cr (FY 2025)Active
Gujarat Ampoules And Vials Pvt Ltd U27310GJ1987PTC010094
Director09 Feb 19901987₹1.93 Cr (FY 2024)Active
Ha Pharma Private Limited U74999MH1988PTC049226
Director14 Oct 19881988₹1.26 Cr (FY 2025)Active
Sng Pharmaceuticals Private Limited U24230MH2003PTC140164
Director25 Apr 20032003₹96.6 Lakh (FY 2025)Active

Board colleagues of Anil Surendranath Gupta

Directorship timeline

Open interactive timeline →
Sng Pharmaceuticals Private Limited
Adit Pharma Private Limited
Zen Pharma Private Limited
Gujarat Ampoules And Vials Pvt Ltd
Premium access

Shareholding and investment profile for Anil Surendranath Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Surendranath Gupta

Anil Surendranath Gupta currently holds 7 directorships: Zen Pharma Private Limited (Director, since 29 May 1998, revenue ₹119 Cr (FY 2024)); Adit Containers Private Limited (Managing Director, since 25 Oct 1983, revenue ₹12.21 Cr (FY 2025)); Adit Pharma Private Limited (Director, since 15 Mar 1991, revenue ₹7.64 Cr (FY 2025)); Adit Leasing And Finance Pvt Ltd (Director, since 01 Jun 1987, revenue ₹2.90 Cr (FY 2025)); Gujarat Ampoules And Vials Pvt Ltd (Director, since 09 Feb 1990, revenue ₹1.93 Cr (FY 2024)); and 2 more.

Anil Surendranath Gupta was first appointed on 25 Oct 1983 as Managing Director at Adit Containers Private Limited. The most recent appointment on record is 25 Apr 2003 at Sng Pharmaceuticals Private Limited.

The 7 current companies of Anil Surendranath Gupta that report revenue have a combined latest revenue of ₹146 Cr: Zen Pharma Private Limited ₹119 Cr (FY 2024); Adit Containers Private Limited ₹12.21 Cr (FY 2025); Adit Pharma Private Limited ₹7.64 Cr (FY 2025); Adit Leasing And Finance Pvt Ltd ₹2.90 Cr (FY 2025); Gujarat Ampoules And Vials Pvt Ltd ₹1.93 Cr (FY 2024); and 2 more.

The current boards of Anil Surendranath Gupta's companies include Amit Gupta (Zen Pharma Private Limited), Renu Anil Gupta (Adit Containers Private Limited), Mukeshbhai Manuprasad Joshi (Gujarat Ampoules And Vials Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available